ALPHAEON Announces Agreement with PhysIOL to Commercialize Advanced Trifocal IOL Technology

Nov 14, 2015, 12:43 ET from ALPHAEON Corporation

IRVINE, Calif., Nov. 14, 2015 /PRNewswire/ -- ALPHAEON Corporation today announced it has entered into a definitive agreement with PhysIOL SA of Belgium, to jointly develop and commercialize an exclusive ALPHAEON-branded Trifocal lens technology.  Specific terms of the agreement were not disclosed.

PhysIOL's dynamic R&D has developed a range of innovative products, designed in partnership with ophthalmic surgeons as well as specialized research centers and universities.  This unique partnership enables ALPHAEON to bring PhysIOL Trifocal lens technology to the US for the first time, providing significant benefits to patients and physicians alike.

"We are very pleased to collaborate with PhysIOL, an innovative leader in advanced Trifocal intraocular lens technology (IOL)," said Robert E. Grant, CEO of ALPHAEON.  "With this new agreement, we will seek to advance the premium category for patients looking for excellent visual acuity outcomes across their range of vision, at near, mid and distance. PhysIOL has already established itself as the leading innovator in Trifocal IOL technology across Europe and Asia.  Together, we'll continue to develop the global self-pay market within ophthalmology, with particular focus in the U.S."

"ALPHAEON's development and regulatory capabilities combined with our expertise in design and manufacturing of Trifocal IOL technologies make this an ideal partnership," said Marc Nolet, CEO, PhysIOL.  "Additionally, we're excited to leverage ALPHAEON's market access through its highly innovative ShoutMD proprietary social commerce platform."

About PhysIOL
Created in 1986, PhysIOL has evolved from the University of Liege, Belgium, and has specialised in the research, development and manufacturing of intraocular implants for cataract surgery.  The company's expertise covers all steps of development and manufacturing of intraocular lenses. It extends from polymer chemistry through to sterilization processes, including modelling and risk-control associated with implantable materials.  For more information, visit

About ALPHAEON Corporation
ALPHAEON Corporation is a social commerce company with the goal of transforming self-pay healthcare by bringing to market highly innovative products and services to promote consumer wellness, beauty and performance. The company works in partnership with board certified physicians ensuring access to leading advancements in lifestyle healthcare. For more information, please visit


Sarah Lilburn, Spark PR (for ALPHAEON)
Tel: 703-569-5906